June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
ecancer – Ruben Mesa on Ropeginterferon’s Superiority in SURPASS-ET Trial
Jun 12, 2025, 10:33

ecancer – Ruben Mesa on Ropeginterferon’s Superiority in SURPASS-ET Trial

ecancer posted on X:

“The Phase 3 SURPASS-ET trial evaluates ropeginterferon alfa-2b versus anagrelide in patients with essential thrombocythaemia. Ropeginterferon shows superior safety and efficacy compared to anagrelide.
Watch full interview with Dr Ruben Mesa.”

More posts featuring Ruben Mesa.